|
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151) |
|
|
|
Titel: |
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151) |
Auteur: |
Si, Lu Zhang, Xiaoshi Shu, Yongqian Pan, Hongming Wu, Di Liu, Jiwei Lou, Fang Mao, Lili Wang, Xuan Wen, Xizhi Gu, Yanhong Zhu, Lingjun Lan, Shijie Cai, Xin Diede, Scott J. Zhou, Yu Ge, Jun Li, Jianfeng Wu, Haiyan Guo, Jun |
Verschenen in: |
Translational oncology |
Paginering: |
Jaargang 12 (2019) nr. 6 pagina's 828-835 |
Jaar: |
2019 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|